Can-Fite BioPharma Ltd. Cash and Restricted Cash
Can-Fite BioPharma Ltd. (CANF) had Cash and Restricted Cash of $5.53 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-26
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.53M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.45M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.83M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.72M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $5.53M 20-F · filed 2026-03-26 |
| 2025-06-30 | $6.45M 6-K · filed 2025-08-28 |
| 2024-12-31 | $4.83M 20-F · filed 2026-03-26 |
| 2024-06-30 | $4.72M 6-K · filed 2025-08-28 |
| 2023-12-31 | $4.28M 20-F · filed 2026-03-26 |
| 2023-06-30 | $3.46M 6-K · filed 2024-08-29 |
| 2022-12-31 | $2.98M 20-F · filed 2026-03-26 |
| 2022-06-30 | $1.71M 6-K · filed 2023-08-31 |
| 2021-12-31 | $4.39M 20-F · filed 2025-04-14 |
| 2021-06-30 | $7.54M 6-K · filed 2022-08-25 |
| 2020-12-31 | $8.27M 6-K · filed 2022-08-25 |